Dr. Abidi Pharmaceutical Laboratories (DABID) balance sheet
Assets, liabilities and equity at the close of each period
Fundamental analysis of DABID on Fundai: DABID Fundamental Analysis, Mehr 1405: Profit Forecast and Valuation
- Ticker
- DABID
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Property, plant and equipment | 61,266,618 | 50,614,807 | 47,053,773 | 26,104,235 | 15,084,779 | 11,945,109 |
| Intangible assets | 591,044 | 69,087 | 69,080 | 69,079 | 35,569 | 37,971 |
| Long-term investments | 33,769,324 | 16,286,111 | 5,186,757 | 3,465,616 | 277,019 | 70,603 |
| Total non-current assets | 95,626,986 | 66,970,005 | 52,309,610 | 29,638,930 | 15,397,367 | 12,053,683 |
| Orders and prepayments | 107,641,191 | 21,881,155 | 10,638,367 | 13,887,900 | 10,194,738 | 5,526,174 |
| Inventory of materials and goods | 142,615,693 | 39,995,866 | 39,632,373 | 30,073,794 | 16,479,658 | 10,227,464 |
| Trade and other receivables | 111,696,810 | 40,700,694 | 23,938,684 | 19,273,856 | 10,863,769 | 6,274,709 |
| Short-term investments | 34,630 | 560,393 | 137 | 1,275,178 | 2,278,961 | 137 |
| Cash | 3,223,976 | 12,071,191 | 2,767,158 | 2,249,168 | 579,947 | 277,500 |
| Total current assets | 365,212,300 | 115,209,299 | 76,976,719 | 66,759,896 | 40,397,073 | 22,305,984 |
| Total assets | 460,839,286 | 182,179,304 | 129,286,329 | 96,398,826 | 55,794,440 | 34,359,667 |
| Capital | 56,000,000 | 41,000,000 | 25,000,000 | 25,000,000 | 4,500,000 | 4,500,000 |
| Legal reserve | 5,600,000 | 3,237,530 | 2,262,393 | 1,962,040 | 450,000 | 450,000 |
| Retained earnings (accumulated losses) | 116,410,196 | 24,476,948 | - | 14,788,011 | 8,647,475 | 8,304,579 |
| Total equity | 178,010,196 | 83,714,478 | 53,508,215 | 41,750,051 | 22,597,475 | 13,254,579 |
| Long-term financial facilities | 48,124,321 | 20,369,534 | 20,486,779 | 9,369,554 | 222,221 | 0 |
| Employee end-of-service benefits provision | 7,315,437 | 4,031,035 | 2,697,393 | 1,877,108 | 1,078,414 | 661,582 |
| Total non-current liabilities | 55,439,758 | 24,400,569 | 23,184,172 | 11,571,317 | 5,241,637 | 1,599,980 |
| Trade and other payables | 99,659,487 | 19,414,235 | 14,499,924 | 7,372,820 | 1,684,683 | 2,162,579 |
| Tax payable | 19,554,554 | 9,769,189 | 6,442,671 | 5,971,155 | 2,957,733 | 1,815,795 |
| Dividends payable | 192,353 | 2,908,929 | 28,347 | 23,804 | 25,298 | 206,324 |
| Financial facilities | 105,271,444 | 39,609,708 | 31,623,000 | 28,051,936 | 22,141,836 | 14,375,375 |
| Total current liabilities | 227,389,332 | 74,064,257 | 52,593,942 | 43,077,458 | 27,955,328 | 19,505,108 |
| Total liabilities | 282,829,090 | 98,464,826 | 75,778,114 | 54,648,775 | 33,196,965 | 21,105,088 |
| Total equity and liabilities | 460,839,286 | 182,179,304 | 129,286,329 | 96,398,826 | 55,794,440 | 34,359,667 |
Reporting periods
77 periods are on file for this report, from the period ending 1380/12/29 to the period ending 1405/06/31.